New Technegas Technology

The Foundation helped bring this new device to Gatineau’s nuclear imaging team. The new technology allows patients aged 40 and under, as well as pregnant women, to benefit from nuclear imaging while receiving greatly reduced radiation doses. It is also used to reduce secondary kidney diseases linked to the use of intravenous contrast agents in people over 65 years of age.

News

What to watch

Pas d'événements

Newsletter

Keep up with the latest news on the Gatineau Health Foundation, by subscribing to our newsletter!

I subscribe